Response to flutamide, as second-line therapy after bicalutamide, predicts efficacy of abiraterone, not that of enzalutamide

OBJECTIVE: The objective of this retrospective study was to evaluate whether the effect of second-line therapy of flutamide after bicalutamide can predict the response to abiraterone. RESULTS: Thirty-four patients received abiraterone and 32 received enzalutamide after treatment with second-line flu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakai, Yasushi, Tanaka, Nobumichi, Miyake, Makito, Inoue, Takeshi, Anai, Satoshi, Fujimoto, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975444/
https://www.ncbi.nlm.nih.gov/pubmed/29843816
http://dx.doi.org/10.1186/s13104-018-3453-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975444/
https://www.ncbi.nlm.nih.gov/pubmed/29843816
http://dx.doi.org/10.1186/s13104-018-3453-z

Ejemplares similares